MK-7625A-034: Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Subjects with Complic

Project: Research project

Project Details

StatusActive
Effective start/end date10/11/188/31/50

Funding

  • Merck Sharp & Dohme Corp